PROSCA & BLADDR 2022

 

PROSCA & BLADDR 2022
T

Urinary Biomarkers in Bladder Cancer Surveillance: Where Do We Stand?

By PROSCA & BLADDR 2022 FEATURING Tobias Klatte
By PROSCA & BLADDR 2022 FEATURING Tobias Klatte
56 views
December 28, 2022
Comments 0
Login to view comments. Click here to Login
BLADDR
23:04

Neoadjuvant Systemic Therapy for MIBC

PROSCA & BLADDR 2022

T. Powles

569 views
14:45

Update on Perioperative Systemic Therapies for UTUC

PROSCA & BLADDR 2022

K. Gust

87 views
15:26

New Roadmaps for Bladder Preservation in High-Risk NMIBC in 2022

PROSCA & BLADDR 2022

J. Irani

62 views
13:03

The Role of Systemic Therapy for Bladder Preservation Strategies in …

PROSCA & BLADDR 2022

A. Bamias

63 views
06:54

Intravesical IO in High Risk NMIBC: A HGUCG Study

PROSCA & BLADDR 2022

C. Fragkoulis

23 views
28:06

Multidisciplinary Management of Pts With MIBC: Real World Patient Ca…

PROSCA & BLADDR 2022

M. De Santis, A. Choudhury, A. Drakaki, T. Klatte

58 views
10:09

Transurethral Resection of Bladder Tumor

PROSCA & BLADDR 2022

M. Moschini

25 views
13:52

Genomic and Tumor Characterisation of UTUC

PROSCA & BLADDR 2022

E. Comperat

51 views
11:57

Clinical Utility of ctDNA Analysis in Bladder Cancer

PROSCA & BLADDR 2022

B. Szabados

86 views
12:57

The Role of Palliative and Best Supportive Care in Bladder Cancer

PROSCA & BLADDR 2022

D. De Maeseneer

36 views
16:45

Lessons From Failed Clinical Trials for Bladder Cancer

PROSCA & BLADDR 2022

R. Jones

18 views
38:03

Multiple Cases Discussion: Oligometastatic Bladder Cancer

PROSCA & BLADDR 2022

V. Fonteyne, K. Gust, U. Vogl, P. Grivas

121 views
15:42

Transurethral Resection of Bladder Tumor: Challenges and Opportuniti…

PROSCA & BLADDR 2022

M. Moschini

16 views
14:03

Considerations for Radical Cystectomy

PROSCA & BLADDR 2022

B. Konety

23 views
17:44

RT of the Bladder: Clinical Practice and Recent Advancements

PROSCA & BLADDR 2022

A. Choudhury

85 views
12:39

The Emerging Role of Maintenance Therapy in Bladder Cancer

PROSCA & BLADDR 2022

R. Jones

106 views
16:02

The Growing Landscape of Antibody-Drug Conjugates in Advanced UC

PROSCA & BLADDR 2022

P. Grivas

126 views
13:35

Clarifying the Position of Immunotherapies for mUC

PROSCA & BLADDR 2022

B. Szabados

57 views
06:37

DEBATE: Are We Evolving Towards a Platinum-Free Future in Bladder Ca…

PROSCA & BLADDR 2022

M. De Santis

59 views
07:13

DEBATE: Are We Evolving Towards a Platinum-Free Future in Bladder Ca…

PROSCA & BLADDR 2022

A. Bamias

92 views
07:19

Final Results of the HIVEC-HR Randomised Trial Comparing Hyperthermi…

PROSCA & BLADDR 2022

F. Guerrero-Ramos

47 views
05:26

Concurrent CRT for MIBC Using 5-Fluorouracil vs. Capecitabine: A Nat…

PROSCA & BLADDR 2022

L. van Hoogstraten

64 views
10:43

Assessment of Molecular Biomarkers for Bladder Cancer Diagnosis, Pro…

PROSCA & BLADDR 2022

H. El Ahanidi

50 views
23:34

Bladder Cancer Case Discussion: Staging and Follow-Up of Pts With No…

PROSCA & BLADDR 2022

T. Klatte, D. Mitropoulos, J. Irani, R. Meijer, M. Moschini, N. James

96 views
08:46

Bladder Cancer: Is It Time to Revise the Pathway?

PROSCA & BLADDR 2022

N. James

300 views
09:34

Radical Cystectomy With Ileal Conduit: Lessons to Be Learned

PROSCA & BLADDR 2022

R. Meijer

69 views
10:19

Uro-Stoma Care: Where Are We Now

PROSCA & BLADDR 2022

B. Thoft Jensen

24 views
15:01

Urinary Biomarkers in Bladder Cancer Surveillance: Where Do We Stand?

PROSCA & BLADDR 2022

T. Klatte

56 views